New-wave diagnostics
作者： Monya Baker
DOI: 10.1038/NBT0806-931
关键词: Data science 、 Biotechnology 、 Pharmacogenomics 、 Engineering 、 Breed 、 Genomics
摘要: A new breed of high-cost diagnostics are entering a commercial and regulatory environment that isn't designed for them. Can they prosper?
nature.com
sci-hub.se 参考文章(2)
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark, None, A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer The New England Journal of Medicine. ,vol. 351, pp. 2817- 2826 ,(2004) , 10.1056/NEJMOA041588
Marc J. van de Vijver, Yudong D. He, Laura J. van 't Veer, Hongyue Dai, Augustinus A.M. Hart, Dorien W. Voskuil, George J. Schreiber, Johannes L. Peterse, Chris Roberts, Matthew J. Marton, Mark Parrish, Douwe Atsma, Anke Witteveen, Annuska Glas, Leonie Delahaye, Tony van der Velde, Harry Bartelink, Sjoerd Rodenhuis, Emiel T. Rutgers, Stephen H. Friend, René Bernards, A Gene-Expression Signature as a Predictor of Survival in Breast Cancer The New England Journal of Medicine. ,vol. 347, pp. 1999- 2009 ,(2002) , 10.1056/NEJMOA021967